<DOC>
	<DOC>NCT01301586</DOC>
	<brief_summary>The purpose of this study is to evaluate a novel, combination product for the treatment of acne vulgaris in females</brief_summary>
	<brief_title>A Novel Combination Oral Agent to Treat Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<mesh_term>Equol</mesh_term>
	<criteria>Healthy females 13 years of age or older Nonpregnant, nonlactating females Signed written informed consent form Must be able to understand and be willing to follow all study instructions Have a clinical diagnosis of acne vulgaris Female subjects who are pregnant or nursing Any concomitant dermatologic condition that may affect outcome measures Concurrent use of any other medication to treat acne vulgaris Have a history or clinical evidence of any other active acute or chronic medical disease or condition considered by the principal investigator as unsuitable for the study Are currently using any other investigational agent or device Have participated in any other clinical study within 90 days prior to enrollment Employees or family members of sponsor or research site</criteria>
	<gender>Female</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>